Board On Health Sciences Policy / Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions et al. Regulatory Processes for Rare Disease Drugs in the United States and European Union - Flexibilities and Collaborative Opportunities. National Academies Press, 2024.

eng

Herausgeber: Carolyn K. Shore / Carson W. Smith / Jeffrey P. Kahn / Tequam L. Worku

Regulatory Processes for Rare Disease Drugs in the United States and European Union

Flexibilities and Collaborative Opportunities

National Academies Press
2024

Taschenbuch
386 Seiten
ISBN 9780309726559

Mit Beiträgen von: Board On Health Sciences Policy, Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions, Engineering National Academies of Sciences und Health And Medicine Division

52,00 €

inkl. MwSt.
zzgl. Versand

Auf Lager